Jiangsu Pacific minok bio Pharmaceutical Co., Ltd
  • Meplazumab was approved for phase I/II clinical trial for the treatment of COVID-19 pneumonia by China NMPA on March 28, 2020.
  • March 28,2020

  • PREVIOUS:Meplazumab was approved for pha...
  • NEXT:PMBP had a successful Pre-IND m...
    Stay up to date on Pacific Meinuoke
    © Pacific Meinuoke         Legal Notice       苏ICP备10218680号-1